Danaher's proposed acquisition of GE BioPharma has been cleared in South Korea, conditional on a divestment package.
The Korea Fair Trade Commission has granted approval to Danaher's $21.4 billion acquisition of the biopharma unit of GE Healthcare's Life Sciences, an affiliate of General Electric, on condition that eight of the companies' bioprocessing businesses